This version of Wegovy is the first oral GLP-1 specifically approved for chronic weight management, while Rybelsus is FDA-approved for blood sugar control in adults with type 2 diabetes
The warnings target statements on websites and in promotional materials that the FDA considers to be false or misleading
Pharmacological treatments that differentially target the pathophysiological mechanisms governing both obesity and OSA have been tested with some success, either as monotherapy or as adjunct therapies to other therapeutic approaches
Mitchell JL, Lyons HS, Walker JK, Yiangou A, Grech O, Alimajstorovic Z, Greig NH, Li Y, Tsermoulas G, Brock K, Mollan SP, Sinclair AJ (2023) The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
BMJ Open 11 , e047993 (2021)
Rhythm Pharma is modulating the MC4R and POMC pathways in rare genetic (congenital) forms of obesitythough this work may not translate beyond these populations
